Neuroinflammation in Alzheimer's disease and mild cognitive impairment: A field in its infancy

Journal of Alzheimer's Disease

Volumn 19, Issue 1, 2010, Pages 355-361

  McGeer, Edith G ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Amyloid ; Astrocytes; Complement; Hydrogen sulfide; Microglia; Neurotoxicity

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; COMPLEMENT; FREE RADICAL; HYDROGEN SULFIDE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; PENTRAXIN; STABLE ISOTOPE; TUMOR NECROSIS FACTOR;

ALZHEIMER DISEASE; ASTROCYTE; CELL CULTURE; COMPLEMENT ACTIVATION; DOWN REGULATION; ENCEPHALITIS; HUMAN; ISOTOPE LABELING; MICROGLIA; MILD COGNITIVE IMPAIRMENT; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; REVIEW; TRANSGENIC MOUSE; UPREGULATION;

EID: 75149118999     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1219     Document Type: Review

References (57)

1. Neuroinflammation Working Group (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
2. Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJ, van Gool WA,. Hoozeman JJ (2006) The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Trans 111, 1685-1695. (Pubitemid 44657664)
3. McGeer PL, Rogers J, McGeer EG (2006) Inflammation, antiinflammatory agents and Alzheimer disease; the last 12 years. J Alzheimers Dis 9, 271-276.
4. Skaper SD (2007) The brain as a target for inflammatory processes and neuroprotective strategies. Ann N Y Acad Sci 1122, 23-34.
5. Schwab C, McGeer PL (2008) Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13, 359-369.
6. Del Rio Hortega P (1919) El 'tercer elemento' de los centros nerviosa. Poder fagocitario y movilidad de la microglia. Bol Soc Esp Biol Ano ix, 154-165.
7. Van Furth R (1982) Current view on the mononuclear phagocyte system. Immunobiol 161, 178-185.
8. Hashioka S,.Klegeris A, McGeer PL (2009) Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity. Exp Neurol 217, 177-183
9. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M (2005) Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci 29, 381-393.
10. Zhu Y, Bickford PC, Sanberg P, Giunta B, Tan J (2008) Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase. Rejuvenation Res 11, 891-901.
11. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S (2005) Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13, 950-958.
12. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318. (Pubitemid 40746128)
13. Hoozemans JJ, Veehuis R,. Rozemuller JM, Eikelenboom P (2006) Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci 24, 157-165.
14. Gulyas B, Makkai B, Kasa P, Gulya K, Bakota L, Varszegi S, Beliczai Z, Andersson J, Csiba L, Thiele A, Dyrks. T,. Suhara T, Suzuki K, Higuchi M,. Halidin C (2009) A comparative autoradiographic study in post mortem whole hemisphere slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Neurochem Int 54, 28-36.
15. Venneti S,Wang G, Nguyen J,Wiley CA (2008) The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J Neuropathol Exp Neurol 67, 1001-1010.
16. Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M, Hallett M, Herscovitch P, Eckelman WC, Carson RE, Rapoport SI (2008) Imaging neuroinflammation in Alzheime's disease with radiolabeled arachidonic acid and PET. J Nucl Med 49, 1414-1421.
17. Herber DL, Mercer M, Roth LM, Symmonds K, Maloney J, Wilson N, Freeman MJ, Morgan D,.Gordon MN (2007) Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol 2, 222-231.
18. Colton CA, Wilcock DM, Wink DA, Davis J, Van Nostrand WE,.Vitek MP (2008) The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J Alzheimers Dis 15, 571-587.
19. Miklossy J, Martins R, Darbinian N, Khalili K,.McGeer PL (2008) Type 2 diabetes: local inflammation and direct effect of bacterial toxic components. Open Path J 2, 86-95.
20. McGeer PL, Sibley J (2005) Sparing of age-related macular degeneration in rheumatoid arthritis. Neurobiol Aging 26, 1199-1203.
21. Benveniste EN (1998) Cytokine actions in the central nervous system. Cytokine Growth Factor 9, 259-275.
22. Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular clues to biological function. Trends Neurosci 20, 570-577.
23. Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21, 6480-6491.
24. Chao CC, Hu S, Sheng WS, Bu D,. Bukrinsky MI, Peterson PK (1996) Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia 16, 275-284.
25. Deshpande M, Zheng J, Borgmann K, Persidsky R, Wu L, Schellpeper C, Ghorpade A, (2005) Role of activated astrocytes in neuronal damage: potential link to HIV-1-associated dementia. Neurotox Res 7, 183-192.
26. Downen M, Amaral TD, Hua LL, Zhao ML, Lee SC (1999) Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 28, 114-127.
27. Mizuno T, Kuno R, Nitta A, Nabeshima T, Zhang G, Kawanokuchi J, Wang J, Jin S, Takeuchi H, Suzumura A (2005) Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes. Brain Res 1066, 78-85.
28. Stewart VC, Sharpe MA, Clark JB, Heales SJ (2000) Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J Neurochem 75, 694-700.
29. Thornton P, Pinteaux E, Gibson RM, Allan SM, Rothwell NJ (2006) Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J Neurochem 98, 258-266.
30. Hashioka S, Klegeris A, Schwab C, McGeer PL (2008) Interferon-?-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging, in press.
31. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999). Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature 400, 10016-10020.
32. Steinberg D (2002) Companies halt first Alzheimer vaccine trial. The Scientist 16, 22.
33. McGeer PL, McGeer E (2003) Is there a future for vaccination as a treatment for Alzheimer's disease? Neurobiol Aging 24, 391-395.
34. Maier M, Peng Y, Jiang L, Seabrook TJ, Carroll MC, Lemere CA (2008) Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice. J Neurosci 28, 6333-6341.
35. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424.
36. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Talber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJH, Silvestri G, Russell SR, Klaver CCW, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102, 7227-7232.
37. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel EA, Pericak-Vance MA (2005) Complement factor H variant increases risk of age-related macular degeneration. Science 308, 419-421.
38. Klein RJ, Zeiss C, Chew EY, Tsai J-T, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389.
39. Bok D (2005) Evidence for an inflammatory process in agerelated macular degeneration gains new support. Proc Natl Acad Sci U S A 102, 7053-7054.
40. Bossu P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G, Trequattrini A, Macciardi F, Spoletini I, Di Iulio F, Caltagirone C, Spalletta G (2007) Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J Neurol Neurosurg Psychiatry 78, 807-811.
41. Culpan D, Prince JA, Matthews S, Palmer L, Hughes A, Love S, Kehoe PG, Wilcock GK (2006) Neither sequence variation in the IL-10 promoter nor presence of IL-10 protein in the cerebral cortex is associate with Alzheimer's disease. Neurosci Lett 408, 141-145.
42. Hu JL, Zhou DX, Zou YX, Zhu ZS, Xu RX, Jiang XD, Zeng YJ (2009) Genetic analysis of interleukin-1A C(-889)T polymorphism with Alzheimer disease. Cell Mol Neurobiol 29, 81-85.
43. Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P, Ly Z, Zheng C, Ma X (2008) Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and saitohin Q7R polymorphisms with Alzheimer's disease. J Neurol Sci 270, 148-151.
44. Sokolova A, Hill MD, Rahimi F, Warden LA, Halliday GM, Shepherd CE (2009) Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol 19, 392-398.
45. Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Stanimirovic DB, Zhang W (2009) Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 34, 95-106.
46. Popp J, Bacher M, Kolsch H, Noelker C, Deuster O, Dodel R, Jessen F (2009) Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. J Psychiatr Res 43, 749-753.
47. Tobinick E, Gross H, Weinberger A, Cohen H (2006) TNFalpha modulation for treatment of Alzheimer's disease: a 6- month pilot study. Med Gen Med 8, 1-11.
48. McGeer PL (2008), Comments Alzheimer Research Forum News 1/21/2008.
49. Klegeris A, Li J, Bammler TK, Jin J, Zhu D, Kashima DT, Pan S, Hashioka S, Maguire J, McGeer PL, Zhang J (2008) Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity. Glia 56, 675-685.
50. Padmanabhan J, Levy M, DicksonDW, PotterH(2006) Alpha- 1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons. Brain 129, 3020-3034.
51. Abe K, Kimura H (1996) The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 16, 1066-1071.
52. Lowicka E, Beltowski J (2007) Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists. Pharmacol Rep 59, 4-24.
53. Qu K, Lee SW, Bian J, Low CM,Wong PT (2008) Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 52, 155-165.
54. Szabo C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6, 917-935.
55. Li L, Rossoni G, Sparatore A, Lee LC, Del Soldato P, Moore PK (2007) Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. Free Radic Biol Med 42, 706-719.
56. Lee M, Schwab C, Yu S, McGeer EG, McGeer PL (2009) Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging 30, 1523-1534.
57. Lee M, Sparatore A, Del Soldato P, McGeer EG, McGeer PL (2009) Hydrogen sulfide releasing agents attenuate neuroinflammation induced by microglial and astrocyte activation. Glia, in press.